Cargando…
Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention
The aim of this current study was to investigate the expression of the tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) in human malignant ovarian tumors, and test TWEAK’s potential role on tumor progression in cell mode...
Autores principales: | Gu, Liying, Dai, Lan, Cao, Cong, Zhu, Jing, Ding, Chuanwei, Xu, Hai-bo, Qiu, Lihua, Di, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587594/ https://www.ncbi.nlm.nih.gov/pubmed/23469193 http://dx.doi.org/10.1371/journal.pone.0057436 |
Ejemplares similares
-
Correction: Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention
por: Gu, Liying, et al.
Publicado: (2013) -
TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013) -
The TWEAK/Fn14/CD163 axis—implications for metabolic disease
por: Ratajczak, Wiktoria, et al.
Publicado: (2021) -
TWEAK/Fn14 Activation Participates in Skin Inflammation
por: Liu, Qilu, et al.
Publicado: (2017) -
The TWEAK Receptor Fn14 is a Novel Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
por: Zhou, Hong, et al.
Publicado: (2012)